Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

ABVC Biopharma & Biolite Entered Into Definitive Agreement With Oncox Biopharma To Collaborate On Combination Therapy; ABVC & Unit Are Eligible To Receive Aggregate License Fee Of $12.5M In Form Of Cash Or Shares Of Oncox Securities; Under Terms Of Deal, ABVC Grants Oncox Exclusive Rights For One Of ABVC's 4 Products In Its Oncology Pipeline

Author: Benzinga Newsdesk | May 24, 2024 07:17am

- SEC Filing

Posted In: ABVC